Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02948387Unknown

Preventing Infections in Orthopaedic Patients

Role: lead

NCT02322827Completed

Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART

Role: lead

NCT02937181Phase 4Unknown

Antibiotic Prophylaxis in Open Fractures

Role: lead

All 3 trials loaded